Please login to the form below

Not currently logged in
Email:
Password:

statutory medicines

This page shows the latest statutory medicines news and features for those working in and with pharma, biotech and healthcare.

No further price cut for non-PPRS drugs in UK

No further price cut for non-PPRS drugs in UK

But industry concerned over long-term plan for statutory medicines on the NHS. ... The DH announced in November 2013 that it would reduce the cost of these statutory medicines by 15% as part of wider drug pricing negotiations and there were concerns that

Latest news

  • ABPI Code updates come into effect ABPI Code updates come into effect

    There is also a grace period for the revised statutory scheme, which covers medicines that pharma companies choose to exclude from the voluntary, but more well-used. ... medicines). Bookings for these exams will be through a new website: http://exams.abpi

  • NHS medicine spend to remain flat for two years NHS medicine spend to remain flat for two years

    to face a price cut on branded medicines to stick to the revised budget. ... In addition to the PPRS announcement, the DH also published details of its plans for statutory medicines - branded drugs sold by companies who do not sign up to the voluntary

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Brexit: can pharma 'take back control' of the narrative? Brexit: can pharma 'take back control' of the narrative?

    For example the sector has continued to see UK patients gaining slower and lower access to innovative medicines than other EU countries. ... Another example is the recent consultation on the Statutory Scheme for branded medicines, which seems to directly

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics